Efficacy and Safety Curcumin in Depression
The Efficacy and Safety of Adjunctive Curcumin for Treatment of Depression: A Randomized, Double-blind, Placebo-controlled Study
2 other identifiers
interventional
40
1 country
1
Brief Summary
Antidepressants generally do not lead to an immediate relief of symptoms. Most people will not see a significant improvement for at least 4 weeks. Studies have generally shown that the full benefits of antidepressant therapy may take as long as 8 to 12 weeks. However, this timeline is variable among individuals.Curcumin is one of the main curcuminoids isolated from this perennial herb. It possesses a variety of pharmacological activities, including anti-inflammatory, antiproliferative, antioxidant, and neuroprotective effects. Curcumin has been found to possess antidepressant action in various animal models of depression. Chronic administration of curcumin has been reported to exert antidepressant-like action in olfactory bulbectomy model of depression in rats. Although the mechanism of the antidepressant effect of curcumin is not fully understood, it is hypothesized that it acts through inhibiting the monoamine oxidase enzyme and modulating the release of serotonin and dopamine.In randomized, double-blind, placebo-controlled study 40 patients will be randomized to receive either 500 mg/day of curcumin or placebo together with antidepressants for 6 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Aug 2010
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 25, 2012
CompletedFirst Posted
Study publicly available on registry
December 17, 2012
CompletedFebruary 7, 2013
December 1, 2012
9 months
July 25, 2012
February 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Hamilton Depression Rating Scale
Change in the scores from baseline at six weeks
Montgomery-Asberg Depression Rating Scale
Change in the scores from baseline at six weeks
Secondary Outcomes (1)
Clinical Global Impression
Change in the scores from baseline at six weeks
Study Arms (2)
curcumin
ACTIVE COMPARATORplacebo
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Males and females in age 20-60 years
- Major depressive episode according to DSM-IV
- Clinical Global Impression Severity Scale scores more than 4
- Hamilton Depression Rating Scale scores more than 21
- Montgomery and Asberg Depression Rating Scale scores more than 22
- Ability and willingness to sign informed consent
You may not qualify if:
- Evidence of organic brain damage
- Mental retardation
- Alcohol or drug abuse
- An unstable medical condition
- Any significant medical or neurological illness
- Patients with a known hypersensitivity to curcumin or other components of the product
- Pregnant women or women who intend to become pregnant
- Receiving any antidepressant and mood-stabilizers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Vladimir Lernerlead
- Tirat Carmel Mental Health Centercollaborator
Study Sites (1)
Tirat Carmel Mental Health Center
Tirat Carmel, 84170, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Bergman, MD
Tirat Carmel
- STUDY DIRECTOR
Vladimir Lerner, MD, PhD
Beersheva Mental Health Center
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- A/Professor, Head of department
Study Record Dates
First Submitted
July 25, 2012
First Posted
December 17, 2012
Study Start
August 1, 2010
Primary Completion
May 1, 2011
Study Completion
June 1, 2011
Last Updated
February 7, 2013
Record last verified: 2012-12